Details for 2019711866

Up to date per 01.04.2026

Actions

Title / Product Name

NEUE PHARMAZEUTISCHE FORMULIERUNG MIT DUALEN NK-1/NK-3-REZEPTOR-ANTAGONISTEN.

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2019711866

EP Publication Number

3765024

E-Number

1633758

Language

PCT Number

EP19056303

Publication Date

20.01.2021 A

22.11.2023 B1

Registration Date

22.11.2023

AT Publication Date

15.12.2023

Application Date

13.03.2019

Registration Number

Priorities

14.03.2018

201862642622 P

IPC

C07D 498/04 20060101AFI20230501BHEP

Maximum Duration of Protection

13.03.2039

Owner

KaNDy Therapeutics Limited400 South Oak Way Reading, Berkshire RG2 6ADGB

Representative

No representatives present

Inventor

TROWER, MikeC/O NeRRe Therapeutics Limited Stevenage Bioscience Catalyst Incubator Building Gunnels Wood Road Stevenage Hertfordshire SG1 2FXGB

KERR, MaryC/O NeRRe Therapeutics Limited Stevenage Bioscience Catalyst Incubator Building Gunnels Wood Road Stevenage Hertfordshire SG1 2FXGB

ELDER, David110 Fordwich Rise Hertford, Hertfordshire SG14 2DEGB

LAZARO, MonicaC/O Catalent Pharma Solutions 2725 Scherer Drive St. Petersburg, Florida 33716US

BUSH, DerekC/O Catalent Pharma Solutions 2725 Scherer Drive St. Petersburg, Florida 33716US

Information about Fees